News and Trends 7 Nov 2018 Belgian Biotech to Abandon Phase III Cell Therapy Trial for Bone Disease Bone Therapeutics is going to discontinue its cell therapy Phase III trial after finding little hope of success for patients with the bone disease osteonecrosis. If all had gone as planned, the full trial would have monitored 118 patients over 24 months. However, an interim analysis on 44 patients after 12 months found little evidence […] November 7, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 2 Nov 2018 This Biotech Uses Metal Alloys to Reshape Your Bones We venture up to the North European climes of Finland this week. In the city of Espoo, Synoste is developing bone lengthening devices made of smart malleable materials. Mission: To modernize bone lengthening devices with new techniques such as using malleable metals with wireless control. People born with discrepancies in limb length often suffer from […] November 2, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2018 Cell Therapy Helps Regenerate Difficult Bone Fractures All patients in a clinical trial run by the Belgian company Bone Therapeutics have seen an improvement in the healing of bone fractures that have had problems healing. Six months after receiving a single dose of the cell therapy developed by Bone Therapeutics, all 21 patients in the Phase I/IIa clinical trial met the primary […] September 14, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 19 Mar 2018 How is Biotech Putting a Spring into the Step of Sportsmen and Women Around the World? Biotech has helped the likes of Cristiano Ronaldo and Rafael Nadal to return to fitness after injury. What else could this technology do to help athletes around the world excel? For as long as I can remember, I’ve been playing sport at every opportunity that I get. Having studied and worked in biotech, I wanted to […] March 19, 2018 - 6 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 8 Mar 2018 Belgian Firm Raises €19M to Fix Spinal Fusion with Cell Therapy Bone Therapeutics has raised €19.5M through a private placement that will fund the completion of clinical trials testing its cell therapy for spinal fusion and other bone diseases. Based in Groselies, Belgium, Bone Therapeutics wants to use cell therapy to help people with bone injuries or diseases regenerate healthy bone. In order to complete its […] March 8, 2018 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email